Fact CheckerSign in

NCT07360223Not yet recruiting

Internalized Symptoms in Adolescents With Autism Spectrum Disorder (ASD) and Typically Developing Adolescents : Gaining Insight Into Coping Strategies and the Psychological Processes Involved

Source: ClinicalTrials.gov · Last updated 29 Jan 2026

Brief summary (registry, in English)

Introduction: Adolescents with autism spectrum disorder (ASD) have more mental health problems than typically developping adolescents (without ASD). Coping strategies are a key concern for adolescents with ASD in managing depressive and anxiety symptoms. Currently, few studies have examined the coping strategies used by adolescents with ASD. The methodological considerations underscore the need for an assessment method tailored to adolescents with ASD. Finally, although current data are still limited, the results suggest that there may be differences between the coping strategies used by adolescents with ASD and typically developing adolescents, thus calling for more in-depth comparative research. Objectives: This study aims to validate a coping strategies assessment method adapted for adolescents with ASD (1) and to examine coping strategies associated with internalizing symptoms (2) Population: 252 participants: 84 adolescents with ASD (1), 84 adolescents with autistic traits but no clinical diagnosis of ASD (2), and 84 typically developing adolescents (3). The age range is 12-17 years. Study design: The study is divided into two parts: a cross-sectional part (T) and a longitudinal part (L). * The cross-sectional part will include three meetings spread over a period of approximately three months (approximately one meeting per month). * The longitudinal part will consist of a meeting scheduled one year after the last meeting of the cross-sectional part.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
252 (estimated)
First submitted
14 Jan 2026
Start date
1 Feb 2026
Primary completion date
31 Dec 2031
Lead sponsor
Université Catholique de Louvain
Diseases
Autism
NCT number
NCT07360223

What you commit to

  • Study type: Observational
  • Planned participants: 252
  • From 1 Feb 2026 to the primary completion date, 31 Dec 2031
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Intellectual disability

Who the study is looking for

  • 12-17 years
  • speak french fluently

Age in the registry: 12 years to 17 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.